| |
| |
|
| Insider
Information: |
Garcia Peter S |
| Relationship: |
Director |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
412,377 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$623,727 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
412,377 |
|
|
| Total
Value |
$623,727 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adhera Therapeutics, Inc |
ATRX |
Chief Financial Officer |
2011-03-31 |
5,000 |
2011-03-31 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Chief Financial Officer |
2011-11-29 |
2,000 |
2011-11-29 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Vice President, CFO |
2018-12-27 |
225,029 |
2013-05-23 |
0 |
Premium* |
|
|
Alx Oncology Holdings Inc |
ALXO |
|
2024-02-14 |
110,348 |
2020-07-21 |
0 |
Premium* |
|
|
Durect Corp |
DRRX |
Director |
2021-12-13 |
70,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRX |
Adhera Therapeutics, Inc |
Chief Financial Officer |
• – – |
2011-03-31 |
4 |
A |
$0.60 |
$3,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2013-05-23 |
4 |
A |
$8.35 |
$105,001 |
D/D |
12,575 |
12,575 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2014-04-10 |
4 |
A |
$8.22 |
$250,299 |
D/D |
30,450 |
43,025 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-01-28 |
4 |
A |
$7.62 |
$250,294 |
D/D |
32,847 |
75,872 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$75,087 |
D/D |
15,169 |
111,041 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2016-01-26 |
4 |
A |
$3.22 |
$325,384 |
D/D |
101,051 |
227,092 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2017-03-04 |
4 |
A |
$2.04 |
$433,845 |
D/D |
212,669 |
447,842 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
55,178 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2023-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
86,738 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
110,348 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2021-08-17 |
4 |
AS |
$65.24 |
$662,299 |
D/D |
(10,000) |
9,331 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2021-08-23 |
4 |
AS |
$70.86 |
$4,448,762 |
D/D |
(60,000) |
9,331 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2021-09-16 |
4 |
AS |
$80.43 |
$114,695 |
D/D |
(1,426) |
9,331 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2021-09-17 |
4 |
AS |
$77.84 |
$895,811 |
D/D |
(11,345) |
9,331 |
0 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2021-10-18 |
4 |
AS |
$54.33 |
$400,793 |
D/D |
(7,229) |
9,331 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2011-11-29 |
4 |
B |
$4.17 |
$8,340 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-08-13 |
4 |
B |
$5.86 |
$58,599 |
D/D |
10,000 |
85,872 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-08-14 |
4 |
B |
$5.79 |
$57,903 |
D/D |
10,000 |
95,872 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-12-14 |
4 |
B |
$3.42 |
$34,245 |
D/D |
10,000 |
121,041 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2015-12-15 |
4 |
B |
$3.64 |
$18,200 |
D/D |
5,000 |
126,041 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2016-08-09 |
4 |
B |
$2.99 |
$29,950 |
D/D |
10,000 |
237,092 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2017-03-24 |
4 |
B |
$1.97 |
$49,401 |
D/D |
25,000 |
472,842 |
2.74 |
- |
|
| ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
• – – |
2020-07-21 |
4 |
B |
$19.00 |
$57,000 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2016-12-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,919) |
235,173 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Vice President, CFO |
• – – |
2017-12-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,818) |
455,024 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
